Daridorexant improved sleep maintenance throughout the entire night, including the last quarter, while also improving next-morning sleepiness.Daridorexant improved next-morning sleepiness compared to placebo from as early as the first day of treatment.Daridorexant improved daytime ability to function and daytime alertness each week over the 3-month treatment duration. Allschwil, Switzerland – April 29, 2025Idorsia Ltd (SIX: IDIA) today announced the publication of “Effect of daridorexant on nighttime wakefu ...

Media relations:Victoire GruxTel.: +33 6 04 52 16 55victoire.grux@capgemini.com Investor relations:Vincent BiraudTel.: +33 1 47 54 50 87vincent.biraud@capgemini.com Q1 2025 Revenues Q1 2025 revenues of €5,553 million, up +0.5% at current exchange rates and a decline limited to -0.4% at constant exchange rates1Bookings of €5,884 million representing a strong 1.06 book-to-bill for the period Paris, April 29, 2025 – The Capgemini Group reported Q1 2025 revenues of € 5,553 million, up +0.5% at current exchange ...

Pratteln, Switzerland, April 29, 2025 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 20, 2025, at 10:00 CEST at Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, Switzerland. The invitation to the AGM with agenda items and explanations will be sent to registered shareholders by mail and can be viewed on Santhera’s website at www.santhera.com/investors-and-media/investor-toolbox/share-bondholder-meetings Agenda (Overview) ...

Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update Successful strategic shift towards a focus on inflammatory and fibrotic diseases, in particular on kidney diseaseVaroglutamstat Phase 2 program shows highly consistent, statistically significant and clinically meaningful improvement of kidney function (eGFR) versus placebo in two independent randomized double-blind placebo-controlled studiesStatistical evidence from meta-analysis of VIVIAD and VIVA-MIND enables ...

GUADALAJARA, Mexico, April 29, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports its consolidated results for the first quarter ended March 31, 2025 (1Q25). Figures are unaudited and prepared following International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). Summary of Results 1Q25 vs. 1Q24 The sum of aeronautical and non-aeronautical services revenues increased by P ...

Sanoma Corporation, Stock Exchange Release, 29 April 2025 at 7:30 EET Sanoma Corporation, Interim Report 1 January–31 March 2025: Improved performance driven by Learning in a seasonally small quarter This release is a summary of Sanoma’s Interim Report 1 January–31 March 2025. The complete report is attached to this release and is also available at www.sanoma.com/en/investors. Q1 2025 The Group’s net sales amounted to EUR 221.1 million (2024: 220.9). In Learning, net sales grew driven by the Netherlands and ...

We hereby provide Consolidated and Company’s financial statements of AB Kauno Energija (company code 235014830) for the year 2024, prepared according to the International Financial Reporting Standards accredited for use in European Union, herewith Consolidated Annual Report and Conclusion of Independent Auditor, approved by the General Meeting of Shareholders. Above mentioned documents also can be found on Company's website http://www.kaunoenergija.lt. Loreta Miliauskienė, Head of the Economic Department, t ...

The General Meeting of Shareholders of AB Kauno Energija (identification code 235014830, address Raudondvario str. 84, Kaunas, LT-47179) that has been held on 28 April 2025 decided to allocate EUR 0.02435 dividend per share. AB Kauno Energija (trading code KNR1L, ISIN code LT0000123010) will close the list of shareholders for dividend payment on 13 May 2025 at the end of the working day of the settlement system. Proceeding from the above, the ex-date is 12 May 2025. From that date the new owner of the share ...

文章核心观点 公司公布2024年财务业绩，完成商业地产和森林资产组合过渡，进行多项重大交易并发行优先股，致力于提升股东价值 [1] 财务业绩 - 2024年净收入为1839万美元，2023年为1849万美元 [1] - 2024年营收为3202万美元，2023年为2797万美元 [1] - 2024年摊薄后归属于股东的净收入为1706万美元，2023年为1726万美元 [1] - 2024年摊薄后普通股每股净收入为12.52美分，2023年为12.69美分 [1] - 2024年末普通股完全摊薄账面价值增至每股92美分，2023年末为80美分 [4] 资产组合过渡 - 2024年公司基本完成商业地产和森林资产组合过渡，过去四年股权基础增加一倍多，普通股完全摊薄账面价值增长53%，从每股60美分增至92美分 [1] 重大交易 - 认购哈利伯顿森林2170万美元参与优先股，有效所有权增至59%，哈利伯顿森林收购穆雷兄弟木材公司锯木厂及相关皇家土地采伐权 [2] - 通过与乔治布朗学院合资，收购多伦多码头大道25号50%权益，扩大学院滨水校区 [7] - 通过与多伦多都市大学和布鲁克菲尔德地产合作伙伴联合运营，收购多伦多皇后东街2号37.5%权益 [7] 资本市场活动 - 完成发行5000万美元的II系列可转换优先股，为未来投资提供资金 [3] 股东价值提升 - 若普通股在较长时间内以大幅低于账面价值的价格交易，公司打算通过正常发行人投标继续回购股份 [4] 公司业务 - 公司直接投资于包括商业、森林、工业和住宅物业在内的实物资产 [5]

SANTIAGO, Chile, April 28, 2025 (GLOBE NEWSWIRE) -- BANCO ITAÚ CHILE (SSE: ITAUCL) announced today that its conference call to discuss the financial results of the first quarter 2025 will be held on Thursday, May 8, 2025, at 9:00 A.M. Santiago time (9:00 A.M. ET). The conference call will be hosted by the by André Gailey, CEO; Emiliano Muratore, CFO; and Andrés Perez, Chief Economist. The results for the first quarter ended March 31, 2025 will be released before the market opens in Santiago, on April 30, 20 ...